Perianth Drugs Private Limited
About Perianth Drugs Private Limited
Data last updated:
Perianth Drugs Private Limited is a private limited company based in Sarkaghat, Himachal Pradesh, India. It operates in the retail trade segment of the trading and commerce sector. It was incorporated on 30 November 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U24231HP2011PTC000007.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vinod Kumar and Meena Kumari.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Nac Shop No. 55 Ward No. 5 Hospital Road, Sarkaghat, Himachal Pradesh, India – 175024.
As per the financials filed for FY 2020, the company reported a revenue of ₹39.65 Lakh, a growth of 36% compared to the previous year. For the same year it recorded a net loss of ₹3,752 (net margin -0.1%) and EBITDA of ₹49,428 (EBITDA margin 1.2%). Revenue has grown at a compounded annual rate (CAGR) of 100% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Perianth Drugs Private Limited's registered office is in Sarkaghat, Himachal Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNac Shop No. 55 Ward No. 5 Hospital Road, Sarkaghat, Himachal Pradesh, India – 175024
- IndustryTrading, Retailers, Retail Trading
To see the full contact details of Perianth Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Perianth Drugs is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Perianth Drugs Private Limited, buy the company report.
Financials of Perianth Drugs Private Limited
FY 2020 filings availablePerianth Drugs Private Limited reported revenue of ₹39.65 Lakh (up 36% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 100% over three years, including 36% growth in the latest year. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹49,428 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3,752 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.2% | ||||
| Net Profit Margin | -0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Perianth Drugs Private Limited, buy the company report.
Board of directors of Perianth Drugs Private Limited
Perianth Drugs has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vinod Kumar | Director | 30 Nov 2011 | 14 Years 11 Months | Current |
| Meena Kumari | Director | 30 Nov 2011 | 14 Years 11 Months | Current |
Peer comparison
Perianth Drugs Private Limited is compared with the 9 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Treon Clothing India Private Limited | ₹39.66 Lakh (FY 2023) | 206.0% | Kozhikode, Kerala, India | |||
| Aadhar Parkashan Private Limited | ₹39.66 Lakh (FY 2024) | 19.0% | Haryana, India | |||
| Apr Overseas Private Limited | ₹39.66 Lakh (FY 2024) | -1.0% | Kolkata, West Bengal, India | |||
| Essentials Tradelink Private Limited | ₹39.66 Lakh (FY 2024) | -27.0% | Indore, Madhya Pradesh, India | |||
| Destiny Fashions Private Limited | ₹39.66 Lakh (FY 2020) | -28.0% | Surat, Gujarat, India | |||
| Perianth Drugs Private Limitedthis company | ₹39.65 Lakh (FY 2020) | -₹3,752 | -0.1% | 36.0% | Sarkaghat, Himachal Pradesh, India | |
| Erefurb Technologies Private Limited | ₹39.65 Lakh (FY 2019) | Bengaluru, Karnataka, India | ||||
| Kalash Power Project Private Limited | ₹39.65 Lakh (FY 2020) | 0.0% | Delhi, India | |||
| Panoptic Exim Private Limited | ₹39.65 Lakh (FY 2024) | 86.0% | Nagpur, Maharashtra, India | |||
| VHV Pharma Private Limited | ₹39.65 Lakh (FY 2024) | 14.0% | Azamgarh, Uttar Pradesh, India |
To see the full peer comparison of Perianth Drugs Private Limited, buy the company report.
Auditor
Perianth Drugs Private Limited is audited by NAVEEN KUMAR AGRAWAL AND ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NAVEEN KUMAR AGRAWAL AND ASSOCIATES | FY 2017 | 023100N |
Shareholding
The shareholding of Perianth Drugs Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Perianth Drugs Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Perianth Drugs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Perianth Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Perianth Drugs Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Perianth Drugs Private Limited has 2 board changes on record since 2011: 2 appointments. The latest: Meena Kumari was appointed as Director on 30 Nov 2011.
Frequently asked questions
Perianth Drugs is an active private limited company based in Sarkaghat, Himachal Pradesh, India. The company works in retailers, within the trading industry. It was incorporated on 30 November 2011 (15+ years old) and is registered under CIN U24231HP2011PTC000007.
Perianth Drugs has 2 current directors:
- Vinod Kumar - Director
- Meena Kumari - Director
The latest financial statements of Perianth Drugs on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Perianth Drugs is U24231HP2011PTC000007. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Perianth Drugs was incorporated on 30 November 2011, making it 15+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
The peers of Perianth Drugs by revenue are Treon Clothing India Private Limited, Aadhar Parkashan Private Limited, Apr Overseas Private Limited, Essentials Tradelink Private Limited, Destiny Fashions Private Limited and 4 more, all in the same principal business activity (wholesale trading).
Meena Kumari was appointed as Director on 30 Nov 2011. Vinod Kumar was appointed as Director on 30 Nov 2011.
The registered office of Perianth Drugs is at Nac Shop No. 55 Ward No. 5 Hospital Road, Sarkaghat, Himachal Pradesh, India – 175024.
Perianth Drugs operates in the trading industry, in the retailers segment.
The compliance status of Perianth Drugs is compliant as of 07 August 2026. The company is actively filing with the Registrar of Companies.
Perianth Drugs can be reached at its registered office: Nac Shop No. 55 Ward No. 5 Hospital Road, Sarkaghat, Himachal Pradesh, India – 175024.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
